Cincinnati Children's Hospital Medical Center Logo

Non-Hodgkin's Lymphoma

Overview

Find detailed information on selected clinical trials for Non-Hodgkin's Lymphoma at Cincinnati Children's Hospital Medical Center.

There are two versions of some of the trials. While they contain the same basic information, one version is geared toward healthcare professionals and the other is geared toward families.

TrialHealthcare
Professional
Version
Family-
Friendly Version
ANHL01P1: A Pilot Study in Children with Newly Diagnosed Advanced B-Cell Leukemia / Lymphoma Treated with LMB / FAB TherapyProfessionalFamily-Friendly
ADVL0319: A Phase I Study of CC-5013 in Pediatric Patients with Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome ProfessionalFamily-Friendly
ANHL0221: A Phase II Study of the Combination of Cyclophosphamide, Prednisone and Rituximab (CPR) in Children, Adolescents and Young Adults with CD20 Positive Post-Transplant Lymphoproliferative Disease (PTLD) following Solid Organ Transplantation (SOT)ProfessionalFamily-Friendly
ADVL0414: A Phase Study of Temozolomide, Oral Irinotecan, and Vincristine for Children with Refractory Solid Tumors Professional Family-Friendly
ADVL0416: A Phase 1 Study of SAHA In Pediatric Patients with Recurrent or Refractory Solid Tumors (Including Lymphomas) and Leukemia Followed by a Phase I Study of SAHA in Combination with 13 Cis-Retinoic Acid for Patients with Selected Recurrent/Refractory Solid TumorsProfessionalFamily-Friendly
ADVL0612: A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid TumorsProfessionalFamily-Friendly
NCI-07-C-0040: A Phase I Trial of the Monoclonal Antibody HGS-ETR2 (Lexatumumab) in Patients with Refractory Pediatric Solid TumorsProfessionalFamily-Friendly
ANHL06P1: A Phase I/II Pilot Study of Ifosfamide, Carboplatin, Etoposide, and Monoclonal Antibody SGN-30 in Pediatric Patients with CD30-Positive Recurrent Anaplastic Large Cell LymphomaProfessionalFamily-Friendly

Contact the Cancer Center at Cincinnati Children's